Browse > Article
http://dx.doi.org/10.5999/aps.2020.00549

Cutaneous mucormycosis of the lower extremity leading amputation in two diabetic patients  

Coerdt, Kathleen M. (Georgetown University School of Medicine)
Zolper, Elizabeth G. (Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital)
Starr, Amy G. (Department of Pathology, MedStar Georgetown University Hospital)
Fan, Kenneth L. (Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital)
Attinger, Christopher E. (Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital)
Evans, Karen K. (Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital)
Publication Information
Archives of Plastic Surgery / v.48, no.2, 2021 , pp. 231-236 More about this Journal
Abstract
Mucormycosis is an invasive, rapidly progressive, life-threatening fungal infection, with a propensity for diabetic, immunosuppressed, and trauma patients. The classic rhinocerebral variation is most common in diabetic patients. While the cutaneous form is usually caused by direct inoculation in immunocompetent patients. Cutaneous mucormycosis manifests in soft tissue and risks involvement of underlying structures. Tibial osteomyelitis can also occur secondary to cutaneous mucormycosis but is rare. Limb salvage is typically successful after lower extremity cutaneous mucormycosis even when the bone is involved. Herein, we report two cases of lower extremity cutaneous mucormycosis in diabetic patients that presented as acute worsening of chronic pretibial ulcers. Despite aggressive antifungal therapy and surgical debridement, both ultimately required amputation. Such aggressive presentation has not been reported in the absence of major penetrating trauma, recent surgery, or burns.
Keywords
Mucormycosis; Leg ulcer; Amputation; Diabetes mellitus; Wound infection;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Holtom PD, Obuch AB, Ahlmann ER, et al. Mucormycosis of the tibia: a case report and review of the literature. Clin Orthop Relat Res 2000;(381):222-8.
2 Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005;18:556-69.   DOI
3 Wagner L, de Hoog S, Alastruey-Izquierdo A, et al. A revised species concept for opportunistic Mucor species reveals species-specific antifungal susceptibility profiles. Antimicrob Agents Chemother 2019;63:e00653-19.
4 Bonifaz A, Stchigel AM, Guarro J, et al. Primary cutaneous mucormycosis produced by the new species Apophysomyces mexicanus. J Clin Microbiol 2014;52:4428-31.   DOI
5 Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-51.   DOI
6 Garcia-Hermoso D, Hoinard D, Gantier JC, et al. Molecular and phenotypic evaluation of Lichtheimia corymbifera (formerly Absidia corymbifera) complex isolates associated with human mucormycosis: rehabilitation of L. ramosa. J Clin Microbiol 2009;47:3862-70.   DOI
7 Petrikkos G, Skiada A, Lortholary O, et al. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 2012;54 Suppl 1:S23-34.   DOI
8 Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. J Fungi (Basel) 2019;5:26.   DOI
9 Guarner J, Brandt ME. Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev 2011;24:247-80.   DOI
10 Jeong W, Keighley C, Wolfe R, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect 2019;25:26-34.   DOI
11 Stanistreet B, Bell D. Burn wound mucormycosis: a case study on poor wound healing. J Burn Care Res 2017;38:e582-4.   DOI
12 Pierce PF, Wood MB, Roberts GD, et al. Saksenaea vasiformis osteomyelitis. J Clin Microbiol 1987;25:933-5.   DOI
13 Tyll T, Lyskova P, Hubka V, et al. Early diagnosis of cutaneous mucormycosis due to Lichtheimia corymbifera after a traffic accident. Mycopathologia 2016;181:119-24.   DOI
14 Skiada A, Lass-Floerl C, Klimko N, et al. Challenges in the diagnosis and treatment of mucormycosis. Med Mycol 2018;56(suppl_1):93-101.
15 Maliwan N, Reyes CV, Rippon JW. Osteomyelitis secondary to cutaneous mucormycosis: report of a case and a review of the literature. Am J Dermatopathol 1984;6:479-81.   DOI